Neuroinflammatory Signaling in Chronic Insomnia: From Microglial Activation to Sleep-Wake Dysregulation
Description
Chronic insomnia is increasingly understood as a disorder extending beyond behavioral and circadian dysregulation, with growing evidence highlighting a central role for neuroimmune mechanisms. This review examines the contribution of neuroinflammatory signaling to the pathophysiology of chronic insomnia, focusing on microglial activation and its impact on sleep-wake regulation. Under normal conditions, immune mediators such as cytokines participate in sleep homeostasis; however, persistent sleep disturbance promotes a shift toward sustained low-grade inflammation. Clinical and preclinical studies consistently report elevated pro-inflammatory markers, including interleukin-6 and tumor necrosis factor-α, alongside alterations in central immune activity, suggesting a bidirectional interaction between sleep disruption and inflammatory processes. Microglia serve as key mediators linking peripheral immune signals with central neural circuitry. Chronic activation of microglia engages intracellular pathways such as NF-κB, NLRP3 inflammasome, and MAPK signaling, leading to synaptic dysregulation, impaired sleep architecture, and associated cognitive and emotional disturbances. Additional factors, including blood-brain barrier dysfunction and systemic inflammation, further amplify this neuroimmune imbalance. While current pharmacological therapies primarily provide symptomatic relief, they do not adequately target these underlying mechanisms. Emerging approaches aimed at modulating neuroinflammatory pathways and restoring microglial homeostasis may offer more effective, mechanism-based strategies for the management of chronic insomnia.